Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
[Evolution of Devic's neuromyelitis optica spectrum disorders.]
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
On the Structure and functions of gelatinase B/Matrix metalloproteinase-9 in neuroinflammation.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.
Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis.
[Diagnosis and differential diagnosis of demyelinating optic neuropathy in multiple sclerosis.]
Multiple sclerosis: Severity of cognitive deficits in MS linked to disease course.
[Multimodal complex treatment in advanced multiple sclerosis.]
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
The Development of Prophylactic and Therapeutic EBV Vaccines.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.
Fatigue in childhood multiple sclerosis.
Neuroimaging evidence of deficient axon myelination in Wolfram syndrome.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
532
533
534
535
536
537
538
539
540
…
next ›
last »